|
|
Article: Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering its Novel Combination Allergic Rhinitis Product.
- Article from:
- Biotech Week
- Article date:
- June 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Compositions containing both sedative and non-sedative antihistamines and sleep aids", US Patent Application Number 10/943,311. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued (see also Collegium Pharmaceutical, Inc.).
Once issued, this patent along with other previously issued patents will provide broad protection for Collegium's novel modified ...